Malignant melanoma, papillary thyroid carcinoma and Erdheim–Chester disease, associated with both BRAF V600E and mosaic Turner syndrome
- 25 December 2019
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 45 (4) , 512-514
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature reviewBMC Cancer, 2019
- Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutationsJournal of the American Academy of Dermatology, 2018
- Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort studyInternational Journal of Cancer, 2016
- Mutations of theBRAFgene in human cancer, by Davieset al. (Nature2002; 417: 949-54)Clinical and Experimental Dermatology, 2013
- X‐chromosome‐located microRNAs in immunity: Might they explain male/female differences?BioEssays, 2011
- Nevi and Melanoma: Lessons from Turner’s SyndromeDermatology, 2001